Multiple PPI dosage form

Details for Australian Patent Application No. 2005264864 (hide)

International Classifications

Event Publications

18 January 2007 PCT application entered the National Phase

PCT publication WO2006/009602 Priority application(s): WO2006/009602

25 November 2010 Alteration of Name

The name of the applicant has been altered to Takeda Pharmaceuticals North America, Inc.

11 August 2011 Application Accepted

Published as AU-B-2005264864

8 December 2011 Standard Patent Sealed

26 July 2012 Application for Amendment

The nature of the amendment is: Amend the patentee name from Takeda Pharmaceuticals North America, Inc. to Takeda Pharmaceuticals U.S.A., Inc. . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.